Yuriko Morita‐Hoshi

Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer

Miho Kaida, Yuriko Morita‐Hoshi, Atsuko Soeda et al. · Journal of Immunotherapy · 2010 · 113 citations

Surgical Oncology, Immunology, Immunoediting +19

Hyperglycemia During the Neutropenic Period Is Associated With a Poor Outcome in Patients Undergoing Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Shigeo Fuji, Sung Won Kim, Shin‐ichiro Mori et al. · Transplantation · 2007 · 86 citations

Regular Dose of Gemcitabine Induces an Increase in CD14+ Monocytes and CD11c+ Dendritic Cells in Patients with Advanced Pancreatic Cancer

Atsuko Soeda, Yuriko Morita‐Hoshi, Hiroaki Makiyama et al. · Japanese Journal of Clinical Oncology · 2009 · 68 citations · Full text

Immunology, Immune Regulation, Immunoediting +21

Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

Shigeo Fuji, Sung Won Kim, Takahiro Fukuda et al. · Biology of Blood and Marrow Transplantation · 2008 · 65 citations · Full text

Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

Takashi Watanabe, Harumi Kato, Yukio Kobayashi et al. · Cancer Science · 2009 · 64 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Mantle Cell Lymphoma +12